市場調查報告書
商品編碼
1411616
避孕藥市場:依產品、年齡層、給藥途徑、分佈 - 全球預測 2024-2030Contraceptive Pills Market by Product (Combination Pill, Continuous/Extended Pill, Progesterone Pill), Age Group (15-24, 25-34, 35-44), Route of Administration, Distribution - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年避孕藥具市場規模為195.3億美元,預計2024年將達207.6億美元,2030年將達302.7億美元,複合年成長率為6.46%。
全球避孕藥市場
主要市場統計 | |
---|---|
基準年[2023] | 195.3億美元 |
預測年份 [2024] | 207.6億美元 |
預測年份 [2030] | 302.7億美元 |
複合年成長率(%) | 6.46% |
避孕藥是含有合成荷爾蒙的口服藥物,旨在調節女性的月經週期並防止意外懷孕。這些藥物的主要作用是抑制排卵、改變子宮頸黏液以限制精子的通過,以及改變子宮內膜以最大限度地減少受精卵的著床。不同年齡層和文化對計劃生育方法的認知不斷提高,對安全有效避孕藥具的需求也隨之增加。然而,由於市場上有替代避孕方法和不合格產品,消費者取得避孕藥具的機會受到限制。然而,開拓具有更高功效和更少副作用的新配方預計將為避孕市場提供潛在機會。
區域洞察
在美洲,由於廣泛的宣傳宣傳活動、政府支持以及製造商在新避孕藥配方方面的技術進步,避孕藥市場正在擴大。根據美國國家醫學圖書館 (NLM) 的數據,目前美國15 歲至 44 歲的女性中約有 25% 選擇避孕藥作為避孕方法。在歐洲地區,促進計劃生育教育和負擔能力的公共衛生計劃使避孕藥具的使用變得流行。亞太地區面臨中國和印度等人口稠密的經濟體,創造了對負擔得起的避孕藥具的需求並呈現出市場成長前景。此外,許多新興和開發中國家正在透過推出計劃生育教育和宣傳計劃為市場創造機會。
FPNV定位矩陣
FPNV定位矩陣對於評估避孕市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出資訊的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對避孕市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴考察,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更資訊的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1-市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2-市場開拓:我們深入研究利潤豐厚的新興市場,並分析它們在成熟細分市場中的滲透率。
3- 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4-競爭力評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5- 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1-避孕藥市場的市場規模和預測是多少?
2-避孕藥市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些?
3-避孕市場的技術趨勢和法律規範是什麼?
4-避孕藥市場主要供應商的市場佔有率是多少?
5-進入避孕藥具市場的適當型態或策略手段是什麼?
[182 Pages Report] The Contraceptive Pills Market size was estimated at USD 19.53 billion in 2023 and expected to reach USD 20.76 billion in 2024, at a CAGR 6.46% to reach USD 30.27 billion by 2030.
Global Contraceptive Pills Market
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 19.53 billion |
Estimated Year [2024] | USD 20.76 billion |
Forecast Year [2030] | USD 30.27 billion |
CAGR (%) | 6.46% |
Contraceptive pills are oral medications that contain synthetic hormones designed to regulate a woman's menstrual cycle and prevent unintended pregnancy. These pharmaceutical products primarily function by inhibiting ovulation, altering the cervical mucus to restrict sperm passage, and modifying the endometrial lining to minimize implantation of a fertilized egg. The growing awareness about family planning methods among different age groups and cultures has increase the demand for safe and effective contraceptives. However, the presence of alternative contraceptive methods or substandard products in the market limits consumers' utilization of contraceptive pills. Nevertheless, developing new formulations that offer improved efficacy and fewer side effects is expected to create potential opportunities for the contraceptive pills market.
Regional Insights
In the Americas region, the contraceptive pills market is growing owing to widespread awareness campaigns, government support, and technological advancements from manufacturers for new contraceptive pill composition. According to the National Library of Medicine (NLM), Approximately 25% of women in the U.S. aged 15-44 currently use contraception pills as their method of choice. In the European region, public health programs promoting family planning education and affordable prices have gained popularity for the use of contraceptive pills. The Asia Pacific region showcases growth prospects for the market in the face of larger population economies such as China & India, creating demand for affordable contraceptive pills. Further, many emerging & developing countries create an opportunistic landscape for the market through the adoption of family planning education & awareness programs.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Contraceptive Pills Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Contraceptive Pills Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Contraceptive Pills Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Afaxys Pharma, LLC, Amneal Pharmaceuticals, Inc., Apotex Inc., Aurobindo Pharma Limited, Bayer AG, Bionpharma Inc., Cipla Limited, Combe Incorporated, Gedeon Richter PLC, Glenmark Pharmaceuticals Limited, Johnson & Johnson Services, Inc., Julie Product Inc., Lupin Limited, Mankind Pharma Ltd., Mayne Pharma Group Limited, Merck & Co., Inc., Northstar Rx LLC, Perrigo Company plc, Pfizer Inc., Piramal Enterprises Ltd., Sun Pharmaceutical Industries Limited, Syzygy Healthcare Solutions, LLC, Teva Pharmaceuticals, Viatris Inc., and Xiromed, LLC.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Contraceptive Pills Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Contraceptive Pills Market?
3. What are the technology trends and regulatory frameworks in the Contraceptive Pills Market?
4. What is the market share of the leading vendors in the Contraceptive Pills Market?
5. Which modes and strategic moves are suitable for entering the Contraceptive Pills Market?